ARCHIVES

DCCP Board Oks Fur New Concepts

This article is from The Cancer Letter archive.

Vol. 07 No. 29 | July 17, 1981

Download PDF Visit The Full Archive

Related Articles

FDA Approves Velcade For Treatment Of Refractory Multiple Myeloma

May 30, 2003

Seven New Initiatives For NIH Common Fund

February 26, 2010

Radiotherapy Plus Cetuximab May Control Head/Neck Cancer

November 26, 2010

Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial

January 27, 2012

NCCS Networker Volume 10 Issue 1, Spring 1996

April 13, 1996

In Brief: Schweitzer ACS President, Dodd President Elect, FDA Commissioner Resigns Abruptly

November 17, 1989